Primary Antibodies
Secondary Antibodies
Proteins & Peptides
ELISA Kits
About Us
Contact Us
Sign In/Register
0
ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee
Home
Primary Antibodies
CRLF2 Antibodies
Verekitug Biosimilar - Anti-CRLF2 Antibody (PE) (A333646)
Verekitug Biosimilar - Anti-CRLF2 Antibody (PE) (A333646)
Overview
Specifications
Recombinant Antibody
$349
Product Datasheet
Recombinant human monoclonal antibody to CRLF2 (PE) for Flow Cytometry.
100% Guarantee
Price Match Guarantee
Product Size:
100T
Quantity:
1
2
3
4
5
6
7
8
9
10
Add To Cart
Request a Quotation
Custom or Bulk Request
Shipping Information
Freight/Packing Charges:
$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Tags:
Recombinant Antibody
Specifications
Name
Verekitug Biosimilar - Anti-CRLF2 Antibody (PE)
Description
Recombinant human monoclonal antibody to CRLF2 (PE).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Conjugate
PE
Excitation: 565nm, Emission: 578nm
Purification
Affinity chromatography.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% Proclin 300 and 1% BSA.
Storage
Store at 4°C. Do not freeze!
Synonyms
CRL2, Cytokine receptor-like 2, Cytokine receptor-like factor 2, IL-XR, ILXR, Thymic stromal lymphopoietin protein receptor, TSLP receptor, TSLPR
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Verekitug Biosimilar - Anti-CRLF2 Antibody (PE) (A333646)? Please
let us know
so that we can list the citation on this page.
Proteins predicted to interact with CRLF2
Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
CD127 Antibodies
99.9% Relevancy Score
TSLP Antibodies
99.9% Relevancy Score
JAK2 Antibodies
98.1% Relevancy Score
P2Y8 Antibodies
95.3% Relevancy Score
IL-7 Antibodies
94.8% Relevancy Score
IL-33 Antibodies
94.6% Relevancy Score
JAK1 Antibodies
91.7% Relevancy Score
IL-4 Antibodies
88.4% Relevancy Score
IL-13 Antibodies
85.7% Relevancy Score
Top